16 results
8-K
EX-99.1
RLYB
Rallybio Corp
9 Nov 23
Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
8:10am
American Society of Hematology Annual Meeting in December,” said Stephen Uden, M.D., Chief Executive Officer of Rallybio.
Dr. Uden continued, “Our multiple … of the Phase 1 safety and pharmacokinetic study of RLYB212.
Poster presentation of abstract for the ongoing natural history study at the 65th American Society
8-K
EX-99.1
vg4cckz rwdqd1u
8 Aug 23
Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
8:16am
424B3
0kha vodt
12 May 23
Prospectus supplement
4:50pm
8-K
EX-99.1
8kzf1yqlb 806zkza8
9 May 23
Rallybio Reports First Quarter 2023 Financial Results
8:11am
10-K
tenuknc9qkpnl85iytt
15 Mar 22
Annual report
4:31pm
8-K
EX-99.1
88f dvt0i
15 Mar 22
Rallybio Reports Fourth Quarter and Full Year 2021 Financial Results
8:30am
8-K
EX-99.1
s2x81k2
9 Sep 21
Rallybio Corporation Reports Second Quarter 2021 Financial Results and Recent Business Highlights
4:11pm
424B4
ljqlq34cijje4
30 Jul 21
Prospectus supplement with pricing info
8:28am
S-1/A
f559fzn
22 Jul 21
IPO registration (amended)
4:04pm
S-1
lbrfz z8j4p
2 Jul 21
IPO registration
4:28pm
- Prev
- 1
- Next